Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: Editorial.
Volume: 6 Issue: 2
Author(s): Goran Mattsson
Affiliation:
Export Options
About this article
Cite this article as:
Mattsson Goran, Editorial., Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2006; 6 (2) . https://dx.doi.org/10.2174/187152206776359894
DOI https://dx.doi.org/10.2174/187152206776359894 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
Article Metrics
Related Articles
-
Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Current Alzheimer Research Recent Methods for Assessing Osteoporosis and Fracture Risk
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Management of Hypertension in the Acute Phase of Stroke
Current Hypertension Reviews Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement
Current Vascular Pharmacology Acute Gout: The Inflammasome
Current Rheumatology Reviews Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
Current Drug Targets Non-Invasive Diagnostic Tests for Non-Alcoholic Fatty Liver Disease
Current Molecular Medicine T-type Calcium Channels in Health and Disease
Current Medicinal Chemistry Hypoglycemia Induces Tau Hyperphosphorylation
Current Alzheimer Research Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Current Drug Therapy Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention
Current Pharmaceutical Design Profiling of Extracellular Metabolites in CHO-K1 Cells Cultured in Medium with Different Levels of Serum and Glutamine
Current Metabolomics Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry The IGF-I Signaling Pathway
Current Pharmaceutical Design Editorial (Thematic Issue: GPCR-Targeted Drug Development)
Current Drug Targets The Pathology of Alcohol Hangover
Current Drug Abuse Reviews Focus on the Correlations between Alzheimer’s Disease and Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets